Muranen, Taru External Entity

Publications

Sort by

Selected publications

  • mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.  Science translational medicine2013 Academic Article GET IT
    Times cited: 81

Other